Safety and Efficacy of Faricimab in Patients With NPDR (MAGIC)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05681884 |
|
Recruitment Status :
Active, not recruiting
First Posted : January 12, 2023
Last Update Posted : April 19, 2024
|
Sponsor:
Greater Houston Retina Research
Collaborator:
Genentech, Inc.
Information provided by (Responsible Party):
Greater Houston Retina Research
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | March 20, 2026 |
| Estimated Study Completion Date : | April 13, 2026 |